Have a symptom?
See what questions
a doctor would ask.
News » New lung cancer drug offers longer survival hope

New lung cancer drug offers longer survival hope

Tarceva is a new lung cancer drug that has recently been approved. It is claimed to increase survival rates in cancer patients and allows a much better quality of life than treatment using chemotherapy. A downside is the expense of the drug. Rash and dry skin are the other reported side effects.

Related Disease Topics:

Article Source Details

About: New lung cancer drug offers longer survival hope

Date: 20 November 2004

Author: Randi F. Marshall


Related Medical Topics

This summary article refers to the following medical categories:

More News Topics

  • Hospital responsible for second death due to medical error
  • Hospital settles after undiagnosed cervical cancer patient dies
  • Hospital settles out of court over negligence claims during birth
  • Hospital sued for undiagnosed heart condition
  • Hospital sued over sister's death
  • Hospitalisation for depression and bipolar disorder linked to dementia risk
  • Hospitals provide funding for educating children about heart disease
  • Hospitals surgical sanitation procedures under question
  • Hot tub can cause lung infection
  • Household chemical linked to asthma risk

    By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

    Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise